NGR6172 Unit 4 Meds - Matching Activity Exam Questions With Correct Answers

Biguanide - Answer Metformin (Glucophage) Metformin - Answer - inhibits glucose production - decr glucose absorption in small intestine First Line oral agent, safe in pregnancy - Answer Metformin Sulfonyureas - Answer - glipizide (Glucotrol) - glyburide (Diabeta) - glimeperide (Amaryl) Stimulates release of insulin from Pancreas, has a risk of SCD - Answer Sulfonyureas glipizide - Answer Glucotrol glyburide - Answer Diabeta glimeperide - Answer Amaryl Oral Agent that causes hypoglycemia, must give 30 before meals to be effective - Answer Meglitinides Meds that stimulate release if insulin are Meglitinides, name 2. - Answer - repuGLINIDE (Prandil) - nateGLINIDE (Starlix) Meds that increase insulin sensitivity: - Answer Thiazolidinediones (TZD's) Two oral hypoglycemic agents with CV risks - Answer 1) TZD's 2) Sulfonyureas TZD's - Answer - pioGLITAZONE (Actos) - roziGLITIZONE (Avandia) Alpha-Glucose Inhibitiors (AG-I's) - Answer - acarbose (Precose) - miglitol (Glyset) Oral hypoglycemic agent that causes horrible gas. - Answer AG-I's Oral hypoglycemic agents contraindicated in CHF due to its tendency to cause fluid retention: - Answer - pioGLITIZONE or roziGLITIZONE (TZD's) SGLT2-Inhibitors cause incr glucose secretion, name 2: - Answer 1) canAGLIFOZIN (Invokana) 2) dapAGLIFOZIN (Farxiga) DPP4-I's are also called: - Answer "gliptons" DPP4-I's decr breakdown of incretin and production of glucose, name 2: - Answer 1) sitaGLIPTION (Januvia) 2) agoGLIPTON (Nesina) Oral hypoglycemic agent that can cause Pancreatitis: - Answer DPP4-I (Januvia) Oral agent with highest CV risk: - Answer - roziGLITIZONE (Avandia)